Takotsubo syndrome diagnostic criteria.
position papers :Mayo clnic ,HFA and InterTAK Diagnostic Criteria.Takotsubo Syndrome and COVID-19.Noninvasive Multimodality Imaging
in the Diagnosis and Management
of Patients with Takotsubo Syndrome
A lecture on the echocardiographic evaluation of hypertrophic cardiomyopathy. Starts with an overview of the topic then a systematic approach to diagnosis and then a differential diagnosis followed by take-home messages and conclusion.
A lecture on the echocardiographic evaluation of hypertrophic cardiomyopathy. Starts with an overview of the topic then a systematic approach to diagnosis and then a differential diagnosis followed by take-home messages and conclusion.
Occurrence of a mural thrombus in a diseased descending thoracic aorta (atherosclerotic or aneurysmal) is a well-known and commonly encountered vascular entity. However, thrombus formation in a normal appearing descending thoracic aorta (NADTA) is rarely reported in literature so far. We present an
unusual case report with a brief literature review of an aortic mural thrombus (AMT) in descending thoracic aorta in a young male. He presented at our center in the emergency department with acute onset abdominal pain and underwent a contrast enhanced CT scan that confirmed mural thrombus in
NADTA.
12-lead electrocardiogram features of arrhythmic risk: A focus on early repolarization
Caterina Rizzo, Francesco Monitillo, Massimo Iacoviello
Caterina Rizzo, Francesco Monitillo, School of Cardiology, Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy
Massimo Iacoviello, Cardiology Unit, Department of Cardiothoracic, Policlinic University Hospital, 70124 Bari, Italy
Reverse Takotsubo Cardiomyopathy Following General AnaesthesiaPremier Publishers
Reverse takotsubo cardiomyopathy(r-TTC) is a rare condition in which regional wall motion abnormalities affect the basal segments of left ventricle in absence of significant coronary artery disease. The Diagnosis is established by characteristic echocardiographic findings, clinical manifestations, and laboratory features. In this report we demonstrate a case of general anaesthesia induced cardiomyopathy in 21 years old female.
CVD in cancer survivors.Screening of cancer survivors.Chest Radiotherapy .JACC Scientific Expert Panel
( J Am Coll Cardiol 2019;74:905–27 )manifestations of chest and mediastinal radiotherapy .
Management of Takotsubo Syndrome: A Comprehensive ReviewNicolas Ugarte
Takotsubo syndrome (TTS), also known as Takotsubo cardiomyopathy, is a transient left
ventricular wall dysfunction that is often triggered by physical or emotional stressors. Although
TTS is a rare disease with a prevalence of only 0.5% to 0.9% in the general population, it is
often misdiagnosed as acute coronary syndrome. A diagnosis of TTS can be made using Mayo
diagnostic criteria. The initial management of TTS includes dual antiplatelet therapy,
anticoagulants, beta-blockers, angiotensin-converting enzyme inhibitors or aldosterone
receptor blockers, and statins. Treatment is usually provided for up to three months and has a
good safety profile. For TTS with complications such as cardiogenic shock, management
depends on left ventricular outflow tract obstruction (LVOTO). In patients without LVOTO,
inotropic agents can be used to maintain pressure, while inotropic agents are contraindicated
in patients with LVOTO. In TTS with thromboembolism, heparin should be started, and
patients should be bridged to warfarin for up to three months to prevent systemic emboli. Our
comprehensive review discussed the management in detail, derived from the most recent
literature from observational studies, systematic review, and meta-analyses.
Keunikan anatomi small vessel of the brain dan neurovascular unit, kontroversi peran stganasi vena dalam patofisiologi, klasifikasi small vessel disease, variasi kriteria diagnostik, pitfall dalam neuroimaging, pilihan antiplatelet untuk prevensi sekundar, dampaknya bagi outcome pasien, hubungannya dengan gangguan fungsi kognitif.
Hmm, apa lagi nih yang baru?
Pro / Con Debate on Central Blood Pressuremagdy elmasry
The Basis : Forward & Reflected Pulse Waves
Central BP - Pro Side of the Argument
Central BP - Con Side of the Argument
Central BP - Consensus on Clinical Application
FDA-cleared devices for central BP and arterial stiffness assessment
Value of measuring central BP in clinComparative effect of
anti-hypertensive drugs and nitrates
on central systolic BP
ical practice
isolated systolic hypertension in the young
The cardio-metabolic continuum.
Hypertension and global cardio-metabolic risk
Hypertension Continuum Stages
What is the total cardiovascular risk?
What is the residual cardiovascular risk?
Global “Cardio-metabolic” Residual Risk Reduction
Residual CV risk rising from obesity.Metabolic syndrome.From NAFLD (Non-Alcoholic Fatty Liver Disease)
to MAFLD (Metabolic dysfunction-Associated Fatty Liver Disease)
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia
GAA 7-34 times→Normal
GAA 100-1700 times→FRDA
Current Research
into Drug Treatments
for Friedreich ataxia
Best Practice in Rare Diseases
Although CNS involvement dominates the clinical presentation of FRDA ,
CV involvement dictates its prognosis, accounting for ~ 59% of deaths among FRDA patients .
The prognosis is particularly poor for those with progressive LV systolic dysfunction.
Should we screen for and treat childhood dyslipidemia?
The Rationale for ASCVD Prevention by Primordial and Primary Strategies
Pediatric guidelines
Selective Screening
2Treatment algorithm of childhood dyslipidemia
-8 years & 12-16 years
Dyslipidemia and lipid lowering-therapy {LLT}
in women through the course of life. Lipid loering drug safety profile .Aging is associated with an increasing burden of morbidity, especially for CVDs.
Elderly population should be screened for
Main CV risk factors :
T2D , HTN , Smoking , Dyslipidemia & Obesity
Comorbidities : CKD
Geriatric conditions: Functional Impairment
Linking HFpEF and Chronic kidney disease magdy elmasry
Cardio-renal interactions
Introducing nephro-cardiology
{ or cardio-nephrology }
Where are we in 2022 with HFpEF ?CKD in HFpEF { or HFpEF in CKD } Cardiorenal
Syndrome .Four-step
HFA-PEFF diagnostic algorithm
heterogeneity in patients with HFpEF.Phenotyping HFpEF :
Beyond EF.Management of HFpEF .patients with HF on dialysis
Drug Treatment of Chronic Coronary Syndrome: Focus Issue on Ranolazinemagdy elmasry
Chronic Coronary Syndromes .Old and New Anti-anginal Drugs.Sodium channel blocker(Ranolazine)Angina / ischaemiac relief .
Voltage-gated sodium channels (NaVChs).Patient profile to guide drug treatment of
chronic coronary syndromes .Therapeutic algorithm for chronic stable angina according to heart rate and blood pressure.Treatment Options for Microvascular angina / Vasospastic angina.Ranolazine in arrhythmias
Ranolazine in ischemic reperfusion injury
Ranolazine in pulmonary hypertension
Ranolazine in heart failure
Ranolazine in the prevention of chemotherapy‑induced cardiotoxicity
Role in diabetes mellitus
Ranolazine in peripheral arterial disease
Ranolazine in myotonia‑congenita
Ranolazine in hypertrophic cardiomyopathy.Antiarrhythmic properties of ranolazine.Amiodarone +Ranolazine
Strategies to improve adherence to antihypertensive medicationmagdy elmasry
Challenges in hypertension treatment.What is the definition of medication non-adherence?Who is at risk? How should
patients at risk be screened and identified?What are the negative impacts of non-adherence?What is the
practical approach for improving adherence? The ABC taxonomy for medication adherence
Adherence :3 quantifiable components: initiation , implementation , and discontinuationThe five dimensions
of non-adherence
.
Do T2DM drugs have CV benefit for Type 1 Diabetes ?magdy elmasry
T1D Exchange , average A1C levels have not improved .How can adjunctive therapies ( added to insulin ) can help?
The Removal Trial.Three main clinical trials :
DEPICT with dapagliflozin ,
EASE with empagliflozin , and
inTANDEM with sotagliflozin.
Connections Between Hepatic and Cardiovascular Disease,Diagnostic criteria for cirrhotic cardiomyopathy 2005 and 2019.New CCM criteria based
on contemporary CV imaging parameters
LV Systolic Function.
LV Diastolic Dysfunction.cardiac evaluation algorithm for liver transplant candidates
Anti-Diabetics For Cardiac Patients The Proper Selectionmagdy elmasry
Cardiovascular Disease and Type 2 Diabetes.Tight glycaemic control can reduce microvascular complications of T2DM, but does not lower CV risk sufficiently.
Multifactorial intervention, comprising of lowering lipid levels and BP, and use of aspirin, has been shown to reduce vascular complications and mortality.Shifting the Paradigm in Diabetes Care
Treating Diabetes Beyond A1C :Considerations for Cardiovascular Protection.
Peripartum Cardiomyopathy .BOARD scheme for the therapy of patients with acut...magdy elmasry
Definition of peripartum cardiomyopathy;Risk factors for the development of PPCM .Environmental Factors
Vasculohormonal (pregnancy).Genetic Factors Titin-truncating
Variants (TTNtv) .Secretion of prolactin by the anterior pituitary gland, upregulation of endothelial microRNA-146a (miRNA-146a), and placental secretion of soluble fms-like tyrosine kinase receptor 1 (sFlt-1) lead to endothelial dysfunction and cardiomyocyte death.Antisense therapy against microRNA-146a
Prolactin inhibition.bromocriptine .biomarkers in peripartum cardiomyopathy
Thyroid Hormones and Cardiovascular Function and Diseasesmagdy elmasry
Thyroid hormone system.
Thyroid hormone action on the CVS.
Thyroid hormones and cardioprotection.
How does thyroid disease affect the heart?
- Thyroid disease and CV risk factors.
- Thyroid dysfunction and CVD.
Thyroid hormones : a future therapeutic option?
New recommendations for a thyroid and CVD.
Thyroid and CV drugs.
Chronic Obstructive Pulmonary Disease and Heart Failure The challenges facin...magdy elmasry
Chronic Obstructive Pulmonary Disease and Heart Failure
The challenges facing cardiologists and pulmonologists,
prevalence of heart failure in COPD patients .Association of Cardiovascular Disease With Respiratory Disease,An atypical presentation of myocardial infarction (MI) should be considered in every patient presenting with COPD exacerbation ,Cardiovascular and pulmonary disease in the context of inflammation
(“CardioPulmonary Continuum”),The cornerstones of therapy are beta-blockers and beta-agonists ,which as their modes of action suggest oppose each other’s action
The main hemodynamic interactions that may impact on the diagnosis of multiple and mixed Multiple and Mixed Valvular Heart Diseases:HOW TO USE IMAGINGThe interplay of multiple valve pathology.The clinical challenge of concomitant aortic and mitral valve stenosis
.
.
Cancer-Associated Thrombosis.From LMWH to DOACsmagdy elmasry
Cancer-Associated Thrombosis.Risk factors for CAT. Certain types of cancer are associated with higher risk of CAT. Anticoagulant therapy for VTE in patients with cancer
Should You Use DOACs for Cancer-Associated VTE?.Criteria for DOAC use in cancer patients requiring anticoagulation .DOACs + AntiCancer agents
The Progression of Hypertensive Heart Disease.From hypertension to heart failuremagdy elmasry
Staging of Hypertensive Heart Disease.Precipitants and clinical sequelae related to LVH and myocardial fibrosis.Imaging in hypertensive heart disease .Differential diagnosis of LVH.Concentric LVH .Eccentric LVH . Concentric remodeling .linking hypertension and atrial fibrillation
Role of the Renin–Angiotensin–Aldosterone System Inhibition Beyond BP Reductionmagdy elmasry
Hypertension Mediated Organ Damage : How We Prevent It?The Role Of RAAS In Cardiovascular Continuum.Changes in Arterial Diameter in Patients with Arteriosclerosis or Atherosclerosis.Not All Angiotensin-Converting Enzyme Inhibitors Are Equal.Question : ACEIs vs. ARBsIs One Class Better For Cardiovascular Diseases?BP Variability .Central BP
.
Vascular Age &
Arterial Stiffness.Achieving BP Goals.
Cardio-Renal Protection Through Renin–Angiotensin–Aldosterone System Inhibitionmagdy elmasry
Physiological and detrimental roles of RAAS molecules in cardiac, vascular tissues and kidneys.‘cardiovascular continuum’ Barriers In Optimizing RAAS Inhibition.The effects of angiotensin II inhibition and improvement in bradykinin availability
HDL-cholesterol concentrations are inversely associated with CVD.When we consider cardiovascular mortality in women in terms of HDL.Causes of low HDL cholesterol.Lipoprotein subfractions suffer a shift after menopause towards a more atherogenic lipid profile.associations of HDL-C and HDL-P with cIMT and CHD.MESA (Multi-Ethnic Study of therosclerosis. Functional Versus Dysfunctional HDL. High concentrations of HDL - cholesterol are associated with high all-cause mortality in men and women.Improvement of HDL function without necessarily raising HDL-C
Fourth Universal Definition Of Myocardial Infarction (2018)magdy elmasry
Reasons for the elevation of cardiac troponin values
because of myocardial injury.
Spectrum of myocardial injury, ranging from no injury to myocardial infarction. Criteria For MI.Types of MI.Myocardial Infarction with Non-Obstructive Coronary Arteries(MINOCA)
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
Feeding plate for a newborn with Cleft Palate.pptxSatvikaPrasad
A feeding plate is a prosthetic device used for newborns with a cleft palate to assist in feeding and improve nutrition intake. From a prosthodontic perspective, this plate acts as a barrier between the oral and nasal cavities, facilitating effective sucking and swallowing by providing a more normal anatomical structure. It helps to prevent milk from entering the nasal passage, thereby reducing the risk of aspiration and enhancing the infant's ability to feed efficiently. The feeding plate also aids in the development of the oral muscles and can contribute to better growth and weight gain. Its custom fabrication and proper fitting by a prosthodontist are crucial for ensuring comfort and functionality, as well as for minimizing potential complications. Early intervention with a feeding plate can significantly improve the quality of life for both the infant and the parents.
Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...IMARC Group
The global veterinary diagnostics market size reached US$ 6.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032.
More Info:- https://www.imarcgroup.com/veterinary-diagnostics-market
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
1. A fresh look at
Takotsubo Syndrome
Magdy El-Masry
Prof. of Cardiology
Tanta University
CardioEgypt 2021
15th - 18th February 2021
Cairo - Egypt.
2. Today’s talk will include:
How to see the big picture
is not
as easy as you would think
Historical Perspective & Nomenclature
Definition & Diagnostic Criteria
Risk Factors & Triggers
Pathophysiology
Clinical presentation & initial workup
Diagnostic Studies { Cardiac Imaging }
Differential Diagnosis
Does Biological Sex Matter?
Complications
Outcome
Treatment
4. It is now 30 years since Japanese
investigators first described Takotsubo
Syndrome as a disorder occurring
mainly in ageing women, ascribing it to
the impact of multivessel coronary
artery spasm.
5. The LV apical ballooning seen in Takotsubo cardiomyopathy
resembles a traditional Japanese octopus trap.
Journal of the American Academy of PAs33(3):24-29, March 2020.
Japanese octopus trap and Takotsubo cardiomyopathy
6. Reversible LV Dysfunction
Takotsubo Cardiomyopathy
Broken Heart Syndrome
Stress Cardiomyopathy
Apical Ballooning Syndrome
Reverse Takotsubo and
Midventricular Takotsubo Cardiomyopathy
Focal Takotsubo Cardiomyopathy
Takotsubo Syndrome
1990
2020
The table shows the most frequently used names
that have been used for TS.
7. Takotsubo Cardiomyopathy
Broken Heart Syndrome
Takotsubo Syndrome
‘Broken heart syndrome’ is easy to remember and has more appeal for the general
community compared with the name ‘Takotsubo syndrome’.
Thus, it is a popular term used in the media for Takotsubo syndrome , but it is a misnomer.
Valentine’s Day and the Broken Heart Syndrome
( February 14 )
9. Year Publication Criteria
2003 Abe et al. Abe criteria
2004 Bybee et al. Mayo Clinic Diagnostic Criteria
2007 Kawai et al. Japanese diagnosis guidelines
2008 Prasad et al. Mayo Clinic Diagnostic Criteria, revised
2011 Omerovic Gothenburg criteria
2012 Wittstein Johns Hopkins criteria
2013 Redfors et al. Gothenburg criteria, revised
2014 Parodi et al. Takotsubo-Italian Network Proposal
2014 Madias Madias criteria
2014 Redfors et al. Gothenburg criteria, proposed new criteria
2016 Lyon et al. ESC Heart Failure Association Taskforce Criteria
2018 Ghadri et al. InterTAK Criteria
Takotsubo syndrome diagnostic criteria
10. Mayo clinic criteria
New ECG
abnormalities * Absence of
obstructive
CAD
Transient LV
apical akinesis/
dyskinesis
*Without concurrent conditions; head injury/intracranial bleed/
pheochromocytoma/myocarditis/hypertrophic cardiomyopathy
In 2004, the Mayo Clinic group published their diagnostic criteria ,
which are still widely used today
Ann Intern Med 2004; 141: 858.
11. The definition of TS according to the two most recent position papers involves several diagnostic
criteria , most of which are common and include transient RWMAs of the LV and/or RV after a stressful
trigger (emotional, physical, or combined, neurologic disorders, or pheochromocytoma), RWMAs extend
beyond the distribution of a single coronary artery, new and reversible ECG abnormalities, elevated
serum NPs, and relatively small Tp elevation.
Similarities and differences between HFA and InterTAK Diagnostic Criteria.
12. Diagnostic Criteria
Mayo Clinic,
2004
ESC HFA Taskforce,
2016
InterTak
Registry,2018
Transient wall motion
abnormalities
√ √ √
Stress as trigger √ √ √
Neurological trigger √
Coronary artery Absence of atherosclerosis Absence of atherosclerosis Atherosclerosis can coexist
New ECG abnormalities √ √
* √
*
Cardiac biomarkers Troponin √ ** √**
Recovery √
No evidence of myocarditis √ √
No evidence of
phaeochromocytoma
√
Postmenopausal women √
*Also includes QTc prolongation. ** ↑ Troponin ↑ ↑ ↑ NT-proBNP
Importantly, InterTAK criteria describe that the presence of pheochromocytoma and significant CAD are not contradictory to the diagnosis of TTS.
The most widely used diagnostic
criteria are HFA/ESC diagnostic
criteria, which have revised the
earlier Mayo Clinic Criteria .
Recently, the InterTAK Diagnostic
Criteria have been proposed
ECR 2019,14(3) 191-6
14. The Many Triggers of TS
Emotional and
physical stress factors
precipitating TS
TS can be caused by a
variety of stressors, and
some of them may
surprise you.
Eur Hear J, 39 (2018), pp. 2032-2046
15. A Few Words About Takotsubo Syndrome and COVID-19
Covidsubo ?????!!!!!
Octopus
COVID-19
16. Takotsubo Rising During COVID-19?
Stress, Viral Triggers Need Attention
Stress or Virus?
What’s not clear is the extent to which the telltale
characteristics of Takotsubo are directly related to the viral
infection or are caused by stress secondary to the pandemic
and its economic and social effects.
The two distress situations
empower each other, the
COVID and Takotsubo.
Covidsubo
If we have a patient who might be
more emotional, pay attention:
psychological support is very
important to them.
18. This figure draws attention to potential pathophysiological mechanisms for the observed reversible
myocardial dysfunction such as sympathetic overdrive-mediated multi-vessel epicardial spasms,
microvascular dysfunction, the direct toxicity of catecholamines, lipotoxicity, and inflammation.
Clin. Med. 2021, 10(3), 479
The exact
pathophysiology
of the TS is
not known
20. Clinical presentation
Chest pain, dyspnea, syncope, palpitations,
cardiac arrest.
Usually in postmenopausal female and often
preceded by an emotional or physical stress
ECG
ST-segment elevation ,ST-segment depression
T-waves inversion
QTc prolongation
Cannot distinguish between Takotsubo and
STEMI at presentation!!!
21. Biomarkers in Takotsubo cardiomyopathy and AMI. Journal of the American Academy of PAs33(3):24-29, March 2020
Labs “Biomarkers”:
↑ troponin & higher NT-proBNP/troponin ratio than in STEMI
{ TS : NT- proBNP/TnI ratio is 2235 .The troponin level is
lower than in patients with STEMI . AMI : NTproBNP/TnI ratio is 82 }
23. Apical, midventricular, basal (inverted) or focal
hypo/akinesia.
Echocardiography
Absence of culprit obstructive CAD.
Ventriculography identifies the anatomical
variant.
No signs of acute plaque destabilization at
intravascular imaging.
Coronary
angiography and
ventriculography
Edema: transmural edema in the areas of
ventricular dysfunction
Cine: regional wall motion abnormalities
without coronary distribution
LGE: absent (cut-off>5 SD).
Cardiac MRI
Cardiac Imaging in TS
July 2020 Future Cardiology 17(7)
24. TS - Transthoracic four-chamber view showing the hypercontractile
basal segment and the ballooning apical segment
Indian J Anaesth 2017;61:728-35
25. Schematic representation of takotsubo cardiomyopathy. A takotsubo is a pot used to catch an octopus. A A takotsubo is
tied to a rope and submerged in the sea; it is retrieved after an octopus has entered the pot. B The shape of the
takotsubo resembles the configuration of the left ventricle during systole on imaging, such as left ventriculography.
Journal of Nuclear Cardiology volume 26, pages1602–1616(2019)
26. White lesions are the territory of a transient abnormality in LV wall motion. Apical type which
is the so-called takotsubo is most frequent. Some of the other variations are reported such as
mid-ventricular, basal, and focal type. Journal of Nuclear Cardiology volume 26, pages1602–1616(2019
Variation of TS.
There are other variants of TS for which the prevalence is unknown. This may be because they are rare, or alternately,
they may be poorly recognised. These variants include: 1 right ventricular involvement. 2 apical tip sparing variant.
3 biventricular apical dysfunction. 4 isolated RV involvement 5 global dysfunction.
27. Four Types of Takotsubo
Cardiomyopathy.
Among the 1750 study patients, the most
common type of takotsubo (stress)
cardiomyopathy was the apical type
(in 81.7% of patients) (Panels A and B),
followed by the midventricular type (in 14.6%
of patients) (Panels C and D), the basal type (in
2.2% of patients) (Panels E and F), and the
focal type (in 1.5% of patients) (Panels G and
H).
All left ventricular angiograms were obtained in the
right anterior oblique view (30 degrees) during
diastole (left column) and systole (middle column).
In the far right column, the wall-motion
abnormality that was observed
with each type of the disorder is shown, with
red indicating diastole, white indicating
systole, and the dashed line indicating the
location of the wall-motion abnormality.
n engl j med 373;10 nejm.org
September 3, 2015
28. CMR imaging of takotsubo cardiomyopathy.
A Wall motion abnormalities at the mid-ventricular to apical anterior segments with cine imaging as apical ballooning. High signal
intensity with fat-saturated T2-weighted images (fsT2WI) (yellow arrows) due to the myocardial edema (B), but the absence of the late
gadolinium enhancement (LGE) (C) are shown. Journal of Nuclear Cardiology volume 26, pages1602–1616(2019
29. The Importance of
Noninvasive Multimodality Imaging
in the Diagnosis and Management
of Patients with Takotsubo Syndrome
Echocardiography
Cardiac Magnetic Resonance Imaging
Computed Tomography Imaging
Nuclear Imaging
30. Strengths and weaknesses of non-invasive multimodality imaging in TS.
Journal of Echocardiography (2020) 18:199–224
Echocardiography CMR CTA Nuclear imaging
Accessibility ++++ ++ +++ ++
Cost + +++ ++ ++
Radiation risk – – ++ ++++
LV morphology and
function
+++ ++++ ++ +++
RV function ++ ++++ ++ –
MR quantification +++ +++ – –
LVOTO ++++ ++ – –
LV/RV thromb ++ ++++ +++ –
Tissue
characterization
+ ++++ ++ +
Coronary artery
imaging
+ ++ ++++ –
Differential diagnosis
a
:
CAD ++ ++++ ++++ +++
MINOCA + ++++ +++ ++
Myocarditis ++ ++++ ++ +
Usefulness in FU +++ +++ – ++
aCTA can be useful to exclude pulmonary embolism and aortic dissection.
+, low; ++, medium; +++, high; ++++, excellent, – = none.
34. Because clinical presentation of TTS mimics ACS , the differential
diagnosis between the two syndromes is challenging.
To differentiate TS and ACS , the InterTAK Diagnostic Score has been proposed.
If 50 or more points were present, the specificity of TS was 95%.
If score was 31 or less, the specificity of ACS was also 95%.
Eur J Heart Fail. 2017;19(8):1036.
35. The differential diagnosis of patients with Takotsubo Syndrome (TS), Acute Myocardial Infarction (AMI).
Current Cardiology Reviews, 2020, Vol. 16, No. 0 3
36. In STEMI patients with MINOCA
{ MI With Non-Obstructive Coronary Artery Presenting With STEMI }
37. The differential diagnosis of patients with Takotsubo Syndrome (TS), Acute Myocardial Infarction
(AMI) and Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA). Current
Cardiology Reviews, 2020, Vol. 16, No. 0 3
38. European Cardiology Review 2020;15:e20.
CMR imaging is a key investigation in identifying the underlying cause
Differential can include Takotsubo
cardiomyopathy ,plaque erosion ,
myocarditis)
40. Worldwide , 90% of patients with TS are post-menopausal women
Women > Men
41. Biological sex influences health and disease “from womb to tomb”.
The spectrum of acute coronary syndromes :
Compared to men, women present more often NSTEMI , endothelial
erosion is more common in younger female smokers, and Takotsubo
syndrome and spontaneous coronary dissection are typical female
presentations of ACSs
42. The spectrum of ACSs is indeed different between the sexes
Typical female presentations of ACSs
44. Different complications that can occur in Takotsubo syndrome.
Complications are divided into heart failure and functional complications as well as mechanical,
arrhythmic and thromboembolic. Swiss Med Wkly. 2017;147:w14490
45. Overview of in-hospital complications according to their prevalence.
AV, atrioventricular block; LV, left ventricle; LVOTO, left ventricular outflow tract obstruction.
Eur Hear J, 39 (2018), pp. 2047-2062
48. Clinical presentation and subsequent course
Early (first 5 days) outcome Late outcome
Hypotension±shock Prolonged impairment of quality of life a
Respiratory failure, usually secondary to
non-cardiogenic pulmonary oedema
Recurrence of TTS
Ventricular tachyarrhythmias Death, predominantly of cardiovascular
origin
Bradycardia/heart block
Left ventricular (LV) mural
thrombus±systemic embolisation
Death, predominantly from shock
a Reflecting impaired myocardial energetics, ongoing inflammation and variable fibrosis.
Heart,Lung and Circulation (2021) 30,36-44
49. Clinical progress after the first 48 hours generally includes
substantial recovery, as measured by resolution of regional LV
hypokinesis on echo , and also of hypotension.
However, most patients continue to feel lethargic for at least 3
months post onset of symptoms , and many complain of
exertional dyspnoea.
Recovering from takotsubo : Will it happen again?
Recurrence of TS is a relatively rare problem, with a risk of
approximately 1–2% per annum .
Most importantly, it has progressively emerged that the long-
term mortality risk after attacks of TS is similar to that after
acute MI , and that a substantial proportion of these deaths is
of cardiovascular origin.
50. TS can either be benign or a life-threating condition depending on the inciting stress factor.
Overall, TS patients had long-term outcomes comparable to age- and sex-matched ACS patients.
TS patients related to physical stress showed higher mortality rates than ACS patients during long-
term follow-up, whereas patients related to emotional stress had better outcomes compared with
ACS patients.
Based on the type of
triggering event
55. Proposal of acute complications management during Takotsubo syndrome (TTS).
Legend: AV = atrioventricular, BP = blood pressure, CPAP = Continuous positive airway pressure, LVOTO = left ventricular outflow tract
obstruction, LVEF = left ventricular ejection fraction, MCS = mechanical circulatory support, NIV = non-invasive ventilation OAC = oral
anticoagulation, PMK = pacemaker. J.Clin.Med.2021,10, 648
Acute treatment in TS
56. Current literature on long-term management of Takotsubo syndrome patients.
First column shows all potential drugs in TS patients, second one potential benefits, third one current evidence in
literature. Legend: CS = cardiogenic shock, LV = left ventricle, LVOTO = left outflow tract obstruction, MACE= mayor cardiac events,
OAC = oral anticoagulation, TTS = takotsubo syndrome. J.Clin.Med.2021,10, 648
Chronic treatment in TS
58. Key References
R.Elias et al :Current Knowledge and Future Challenges in Takotsubo Syndrome:
Part 1—Pathophysiology and Diagnosis.J. Clin. Med. 2021, 10(3), 479
S.Francesco et al :Current Knowledge and Future Challenges in Takotsubo Syndrome:
Part 2—Treatment and Prognosis.J. Clin. Med. 2021, 10(3), 468
A.R. Lyon et al : Current state of knowledge on Takotsubo syndrome: a position statement from the
Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of
Cardiology.Eur J Heart Fail, 18 (2016), pp. 8-27
J.R. Ghadri et al: International expert consensus document on takotsubo syndrome
(part I): clinical characteristics, diagnostic criteria, and pathophysiology.- Eur Hear J, 39 (2018),
pp. 2032-2046
J.R. Ghadri et al : International expert consensus document on takotsubo syndrome
(part II): diagnostic workup, outcome and management.Eur Hear J, 39 (2018), pp. 2047-2062
K. A .Bybee et al : "Systematic review: transient left ventricular apical ballooning: a syndrome that
mimics ST-segment elevation myocardial infarction". Ann Intern Med 2004; 141: 858.
Medina de Chazal et al :Stress Cardiomyopathy Diagnosis and Treatment : JACC State-of-the-Art
Review JACC 2018 ; 72( 16):1955
59.
60. Drugs recommended to treat takotsubo syndrome (TTS).
Drugs Main indication
Levosimendan
Ejection fraction <55% ( & absence of LVOTO )
With systolic BP >90 mmHg
Beta-blockers LVOTO . QTc <500 msec
ACE inhibitors/ARBs To reduce the rate of recurrence
Diuretics To reduce edema
Nitrates No if LVOTO
BioMed Research International / Volume 2019 |Article ID 6571045
61. Direct and indirect mechanisms leading to myocardial and microvascular injury in SARS-CoV-2 infection
62. Dynamic left ventricular outflow tract obstruction in apical ballooning syndrome
(Takotsubo cardiomyopathy)
Abstract
Patients with apical ballooning syndrome may develop dynamic left ventricular
outflow obstruction due to systolic anterior motion of the mitral valve leaflet and
secondary functional mitral regurgitation, causing decreased cardiac output and
hypotension.
If suspected, bedside echocardiography will quickly confirm this complication.
Positive inotropic/chronotropic agents should be avoided as they may exacerbate
outflow tract obstruction, resulting in further hemodynamic compromise.
63. RV involvement
Reverse McConnell sign
(biventricular
ballooning)
Am J of Cardiology 111,8,1232-1235,2013
In patients with TC, the motion of the basilar and middle segments of the RV free wall is
often hyperkinetic.
However, the motion of the apical segment of the RV free wall is usually hypokinetic,
in the same manner as LV apical motion .
Interestingly, this distinct imaging feature is exactly opposite the classic echo appearance in
patients with acute and massive pulmonary embolism, McConnell's sign, which is defined as
hyperkinesis of the RV apex and hypokinesis of the remaining segments of the RV free wall.
65. Therapeutic algorithm proposal for oral anticoagulation (OAC) management during the
acute phase of Takotsubo syndrome. Santoro et al. Journal of the American Heart Association, 2017;6: e006990
66. Principal conditions to consider in the differential diagnosis of patients with MINOCA
and clues into differential diagnosis. July 2020 Future Cardiology 17(7)
Clinical presentation Clinical presentation ECG Echocardiography Coronary angiography Cardiac MRI
MINOCA
‘Epicardial pattern’: epicardial
spasm; plaque disruption;
nonangiographically
obstructive SCAD
‘Microvascular pattern’:
unstable microvascular
dysfunction,
nonangiographically
obstructive coronary
embolism/thrombosis
Chest pain, dyspnea,
arrhythmias.
Less often heart
failure/cardiogenic shock,
cardiac arrest.
Compared with those patients
with MI-CAD are more
commonly younger and
women.
ST-segment elevation or ST-
segment depression and/or T
waves inversion.
Regional wall motion
abnormalities according with
epicardial coronary artery
distribution (epicardial pattern)
or extended beyond a single
epicardial coronary artery
territory (microvascular
pattern)
Contrast echo (transthoracic or
transesophageal) to search the
source of embolization
Absence of angiographic
obstructive CAD:
– FFR: may be considered in
selected patients with
borderline stenosis.
– Intravascular imaging (IVUS
and OCT): to assess the
presence of coronary plaque
disruption/erosion or SCAD
– Provocative tests
(intracoronary acetylcholine):
to assess the presence of
coronary epicardial or
microvascular vasospasm.
Edema: At sites of wall motion
abnormalities
Cine: Regional wall motion
abnormalities according with
epicardial coronary artery
distribution (epicardial pattern)
or extended beyond a single
epicardial coronary artery
territory (microvascular
pattern)
LGE: At sites of wall motion
abnormalities.
Takotsubo syndrome Chest pain, dyspnea, syncope,
palpitations, cardiac arrest.
Usually in postmenopausal
female and often precepted by
an emotional or physical stress.
ST-segment elevation, T waves
inversion, QTc prolongation
Apical, midventricular, basal
(inverted) or focal
hypo/akinesia.
Absence of culprit obstructive
CAD. Ventriculography
identifies the anatomical
variant.
No signs of acute plaque
destabilization at intravascular
imaging.
Edema: transmural edema in
the areas of ventricular
dysfunction
Cine: regional wall motion
abnormalities without coronary
distribution
LGE: absent (cut-off>5 SD).
MI (with obstructive CAD) Chest pain, dyspnea,
arrhythmias, heart
failure/cardiogenic shock, SCD.
ST-segment elevation (STEMI),
ST-segment depression and/or
T waves inversion (NSTEMI).
Regional wall motion
abnormalities according with
epicardial coronary artery
distribution.
Coronary artery disease with
acute plaque rupture and
thrombus formation.
Edema: Subendocardial or
transmural at sites of wall
motion abnormalities.
Cine: Regional wall motion
abnormalities matching
epicardial coronary artery
distribution
LGE: Bright LGE, typically
subendocardial or transmural
matching epicardial coronary
artery distribution
Myocarditis Chest pain, dyspnea, heart
failure/shock, cardiac arrest.
Often preceded by an infection
ST and/or T wave changes. Global or regional systolic
dysfunction Pericardial
involvement may be also
present.
Absence of obstructive CAD Edema: Subepicardial, basal
and lateral
Cine: Global, or regional
contractile dysfunction.
LGE: Low intensity or bright;
typically focal, ‘patchy’,
subepicardial or midventricular
with a noncoronary
distribution
Echocardiography shows akinesia of apical or midventricular segments leading to systolic dysfunction. The normal basal segments become hypercontractile, giving a ballooned out appearance of the apical or mid-cavity segments [Figure 3]. Ballooning may lead to altered spatial relationships between mitral leaflets and subvalvular apparatus, which may result in MR and dynamic LVOTO causing SAM.
InterTAK Diagnostic Score was developed from the results for International Takotsubo Registry [Eur J Heart Fail. 2017;19(8):1036.] by the InterTAK International Registry Group. The score was developed for differentiating Takotsubo cardiomyopathy from acute coronary syndrome in the acute stage.
InterTAK Diagnostic Score estimates the probability for Takotsubo cardiomyopathy and was found to have high sensitivity and specificity for differentiating it from acute coronary syndrome. If 50 or more points were present, the specificity of Takotsubo cardiomyopathy was 95%. If score was 31 or less, the specificity of acute coronary syndrome was also 95%.
Importantly, the spectrum of different presentations of ACSs is indeed different between the sexes : women present more often with NSTEMI, more commonly have endothelial erosion rather than plaque rupture as the underlying cause, particularly among younger female smokers, and finally Takotsubo syndrome and spontaneous coronary dissection are typical female presentations of ACSs
Table summarises key aspects of the early and late clinical features and complications of TTS.
Conclusions
Overall, TTS patients had long-term outcomes comparable to age- and sex-matched ACS patients. Also, we demonstrated that TTS can either be benign or a life-threating condition depending on the inciting stress factor. We propose a new classification based on triggers, which can serve as a clinical tool to predict short- and long-term outcomes of TTS. (International Takotsubo Registry [InterTAK Registry]; NCT01947621)